Back
Baxter International Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
44
BAX
Baxter International
Last Price:
36.91
Seasonality Move:
3.48%
Sell
28
ALNY
Alnylam Pharmaceuticals
Last Price:
150.14
Seasonality Move:
18.94%
Sell
44
Baxter International (BAX)
is a Sell
Is Baxter International a Buy, Sell or Hold?
- The current Baxter International [BAX] share price is $40.34. The Score for BAX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- BAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $149.96. The Score for ALNY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BAX Stock Price Chart
What is Baxter International's stock price today?
-
The Baxter International share price today is $40.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BAX is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $149.96
The current trend is relatively stagnant and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
BAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.41 | Sell |
| Relative Strength Index (14 RSI): | 44.17 | Sell |
| Chaikin Money Flow: | 90761 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.96 - 42.62) | Sell |
| Bollinger Bands (100): | (38.57 - 42.15) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.71 | Sell |
| Relative Strength Index (14 RSI): | 53.03 | Buy |
| Chaikin Money Flow: | 367415 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (144.91 - 152.87) | Buy |
| Bollinger Bands (100): | (147.47 - 183.29) | Sell |
BAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.51 | Sell |
| 20-day SMA: | 40.85 | Sell |
| 50-day SMA: | 41.74 | Sell |
| 200-day SMA: | 39.45 | Buy |
| 8-day EMA: | 40.42 | Sell |
| 20-day EMA: | 40.79 | Sell |
| 50-day EMA: | 40.99 | Sell |
| 200-day EMA: | 40.93 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 145.48 | Buy |
| 20-day SMA: | 148.17 | Buy |
| 50-day SMA: | 150.12 | Sell |
| 200-day SMA: | 171.94 | Sell |
| 8-day EMA: | 146.25 | Buy |
| 20-day EMA: | 147.41 | Buy |
| 50-day EMA: | 152.23 | Sell |
| 200-day EMA: | 169.4 | Sell |
Baxter International Earnings Growth & BAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.31 per share, and an increase next year of $0.33 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.39 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.49 per share, and an increase next year of $1.85 per share.
Baxter International Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||